ACRC Trials

12/19/2025

New year, fresh start. ✨

ACRC Trials is conducting a weight loss research study using an investigational subcutaneous GLP-1/GIP combination medication for adults living with obesity.

Participants may:

Receive study-related care at no cost
Get access to an investigational medication
Receive up to $5,300 for time & travel (if eligible)

If you’re ready to explore new options for managing your weight, see if you may qualify.

🔗 Learn more: acrctrials.com

Participation is voluntary. The study medication is investigational and not yet approved for general use.

12/16/2025

🧪 New CDC Findings on COVID-19 Vaccination in Children

A recent CDC report, highlighted by CNN, shows that the 2024–2025 COVID-19 vaccine helped reduce emergency department and urgent care visits among children who received the updated vaccine.

Why participate?
✅ Study-related care at no cost
✅ Possible compensation for time & travel
✅ Be part of groundbreaking research
📍 Spots are limited — Contact us today to see if you qualify!
📞 (972) 354-1520 | 🌐 Visit: www.ACRCTrials.com

https://www.cnn.com/2025/12/11/health/covid-vaccine-children-cdc

12/12/2025

Holiday season = travel, gatherings, and lots of exposure. 🎄✨
That’s why flu prevention matters more than ever.

Help Advance Flu Research!
We’re enrolling healthy senior adults for a Flu Vaccine Study comparing two vaccines.

Why join?
✅ Help researchers learn more about preventing the flu
✅ Receive up to $325 for time & travel
✅ No insurance required
✅ All study-related care at no cost

Interested?
Call, text, or fill out the form to see if you qualify.

Let’s protect our communities this season — and help improve flu prevention for the future. 💛

12/01/2025

🚨 Join the Norovirus “Stomach Bug” Vaccine Study
📍 Now enrolling in Carrollton and Plano

Norovirus spreads fast — in daycares, cruise ships, hospitals, and restaurants. It causes sudden nausea, vomiting, and diarrhea lasting 1–3 days. This study is helping researchers develop a potential new vaccine to prevent it.

💰 Receive up to $974 for your time and travel
👵 Ages 60 and older
💪 Must be in good health or have a stable medical condition
🩺 No insurance required to participate

Help advance medical research and protect those most at risk.
Sign up today at acrctrials.com

11/27/2025

Every breakthrough starts with someone willing to help.

We are grateful for our patients, physicians, staff, partners and our community, who make advancing healthcare possible.

Wishing everyone a warm and healthy Thanksgiving! 🍁🍂🦃

11/20/2025

Join a Flu Vaccine Study & Help Advance Research!

At ACRC Trials, we're looking for participants to join our Flu Vaccine Study.
By taking part, you may not only help protect yourself, but you're also supporting the future of flu research and public health.

Eligible participants may receive:

✔ Study-related health exams
✔ Compensation for time & travel
✔ Access to the latest investigational flu vaccine

📍 Learn more and apply at https://1l.ink/SJPFVVT
Let’s move flu research forward — together.

11/14/2025

Join our Norovirus “stomach bug” vaccine study at our Carrollton or Plano locations! 💉
✔ No-cost health exam
✔ Receive up to $974 for time & travel
✔ Access investigational study-related vaccine
Call 469-827-8060 today. Space is limited! Learn more: https://www.acrctrials.com/studies/norovirus-vaccine/

11/13/2025

Help Fight the Stomach Bug – Join a Norovirus Vaccine Study

Are you 60 or older? You may qualify to take part in a clinical research study for a potential Norovirus vaccine.

Participants can receive up to $974 for time and travel.

Join the effort to protect future generations from this common and highly contagious illness.

Now enrolling at acrctrials.com/studies

11/06/2025

💉 Join a Clinical Research Study for Weight Loss
ACRC Trials is now enrolling adults with obesity or overweight-related conditions for a study involving a GLP-1/GIP injectable medication.

✔️ Receive up to $5,300 for your time and travel
✔️ Must have a BMI ≥ 27 kg/m²
✔️ Must be able to attend scheduled visits
✔️ Must be open to an investigational injectable treatment

🔗 Learn more or see if you qualify: ACRCTrials.com

🧪 Today’s Research. Tomorrow’s Medicine.

10/31/2025

Wishing everyone a safe and “spooktacular” Halloween! 🕸️🎃
At ACRC Trials, our mission is to make research less scary and more accessible.
Your participation helps turn medical mysteries into real solutions.

💡 Learn more about our current studies: www.ACRCTrials.com

10/30/2025

Today’s Research. Tomorrow’s Medicine. 🌟

At ACRC Trials, we connect people like you with cutting-edge clinical research that shapes the future of healthcare. 🧬

With locations across Texas - Dallas, Plano, Frisco, Carrollton, Grapevine, Austin, Houston, our experienced medical team provides compassionate care and guidance — every step of the way. 💙

✨ What We Stand For:
• Advancing medicine through innovation
• Prioritizing the health and safety of every participant
• Conducting ethical, high-quality research
• Building a healthier tomorrow for all

Join us in shaping the future of healthcare. Your participation matters. 💪

🔗 Learn more at acrctrials.com

10/27/2025

🔬 New Study: mRNA COVID-19 Vaccines May Help Boost Cancer Immunotherapy

Exciting recent research suggests that mRNA COVID-19 vaccines might do more than protect against SARS-CoV-2 — they may also enhance the immune response against certain cancers.

📢 At ACRC Trials, we’re actively enrolling for adult COVID-19 studies right now. You can take part in advancing treatments, vaccines, or mitigation strategies — and help protect your community in the process.
Why participate?
✅ Study-related care at no cost
✅ Possible compensation for time & travel
✅ Be part of groundbreaking research
📍 Spots are limited — Contact us today to see if you qualify!
📞 (972) 354-1520 | 🌐 Visit: www.ACRCTrials.com

https://www.newscientist.com/article/2500546-mrna-covid-vaccines-spark-immune-response-that-may-aid-cancer-survival/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=currents

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given soon after people start a type of immunotherapy, extending their lives